ProfileGDS4177 / 236830_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 54% 53% 59% 54% 63% 64% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated39.3854
GSM603099KU-812 non-treated37.7653
GSM603098KCL-22 Imatinib-treated50.2859
GSM603097KCL-22 non-treated39.1554
GSM603102JURL-MK1 Imatinib-treated64.2863
GSM603101JURL-MK1 non-treated65.164